David Szeto

David Szeto is a Senior Analyst at Great Point Partners in New York, NY, where he focuses on equity research and investment analysis within the biotechnology and pharmaceutical sectors. In his current role, Szeto evaluates therapeutic companies and innovative life sciences businesses, supporting investment decisions for the firm's healthcare-focused funds.

Previously, Szeto built expertise in biotech equity research at RBC Capital Markets and held business development and licensing roles at Bayer, concentrating on pharmaceutical partnerships and strategic asset acquisition. His career spans both investment advisory and operating roles across the healthcare ecosystem, equipping him with diverse sector insights.

Szeto holds a Doctor of Pharmacy from the University of California, San Francisco, a Master’s in Nano-Engineering from UC San Diego, and a Bachelor’s in Mechanical Engineering and Materials Science Engineering from UC Irvine. His multidisciplinary training underpins his analytical rigor and sector-specific expertise, and he is recognized for contributions to biotech equity research and licensing due diligence in the life sciences investment community.